Furukawa Yasushi, Tanaka Keiko, Isozaki Osamu, Suzuki Atsushi, Iburi Tadao, Tsuboi Kumiko, Iguchi Moritake, Kanamoto Naotetsu, Minamitani Kanshi, Wakino Shu, Satoh Tetsurou, Teramukai Satoshi, Kimura Eizen, Miyake Yoshihiro, Akamizu Takashi
First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
Department of Epidemiology and Public Health, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
J Clin Endocrinol Metab. 2024 Dec 18;110(1):e87-e96. doi: 10.1210/clinem/dgae124.
The mortality rate in thyroid storm (TS) has been reported to be higher than 10%.
We aimed to evaluate the effectiveness of the 2016 guidelines for the management of TS proposed by the Japan Thyroid Association and Japan Endocrine Society.
In this prospective multicenter registry-based study, patients with new-onset TS were registered in the Research Electronic Data Capture (REDCap), a secure web platform. On day 30 after admission, clinical information and prognosis of each patient were added to the platform. On day 180, the prognosis was described.
This study included 110 patients with TS. The median of Acute Physiology and Chronic Health Evaluation (APACHE) II score was 13, higher than the score (10) in the previous nationwide epidemiological study (P = .001). Nonetheless, the mortality rate at day 30 was 5.5%, approximately half compared with 10.7% in the previous nationwide survey. Lower body mass index, shock, and lower left ventricular ejection fraction were positively associated with poor prognosis at day 30, while the lack of fever ≥ 38 °C was related to the outcome. The mortality rate in patients with an APACHE II score ≥ 12 for whom the guidelines were not followed was significantly higher than the rate in patients for whom the guidelines were followed (50% vs 4.7%) (P = .01).
Prognosis seemed better than in the previous nationwide survey, even though disease severity was higher. The mortality rate was lower when the guidelines were followed. Thus, the guidelines are useful for managing TS.
据报道,甲状腺危象(TS)的死亡率高于10%。
我们旨在评估日本甲状腺协会和日本内分泌学会提出的2016年TS管理指南的有效性。
在这项基于前瞻性多中心注册研究中,新发TS患者在安全的网络平台研究电子数据采集(REDCap)中进行注册。入院后第30天,将每位患者的临床信息和预后情况添加到该平台。在第180天,描述预后情况。
本研究纳入了110例TS患者。急性生理与慢性健康状况评估(APACHE)II评分的中位数为13,高于先前全国性流行病学研究中的评分(10)(P = 0.001)。尽管如此,第30天的死亡率为5.5%,约为先前全国性调查中10.7%的一半。较低的体重指数、休克和较低的左心室射血分数与第30天的不良预后呈正相关,而无≥38°C的发热与预后有关。未遵循指南的APACHE II评分≥12的患者的死亡率显著高于遵循指南的患者(50%对4.7%)(P = 0.01)。
尽管疾病严重程度较高,但预后似乎比先前全国性调查更好。遵循指南时死亡率较低。因此,这些指南对TS的管理有用。